Axon Enterprise, Inc. (NASDAQ:AXON – Get Rating) Director Julie A. Cullivan sold 2,013 shares of the company’s stock in a transaction that occurred on Monday, May 22nd. The shares were sold at an average price of $197.58, for a total transaction of $397,728.54. Following the completion of the sale, the director now directly owns 7,062 shares of the company’s stock, valued at approximately $1,395,309.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Axon Enterprise Stock Performance
Shares of AXON opened at $195.80 on Wednesday. Axon Enterprise, Inc. has a 12 month low of $83.01 and a 12 month high of $229.95. The firm has a fifty day simple moving average of $215.96 and a 200 day simple moving average of $197.31. The stock has a market capitalization of $14.47 billion, a price-to-earnings ratio of 103.60 and a beta of 0.95. The company has a current ratio of 3.33, a quick ratio of 2.97 and a debt-to-equity ratio of 0.48.
Axon Enterprise (NASDAQ:AXON – Get Rating) last announced its earnings results on Tuesday, February 28th. The biotechnology company reported $0.36 EPS for the quarter, topping the consensus estimate of $0.08 by $0.28. Axon Enterprise had a net margin of 10.76% and a return on equity of 10.65%. The business had revenue of $336.14 million during the quarter, compared to analysts’ expectations of $303.91 million. Research analysts forecast that Axon Enterprise, Inc. will post 1.59 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Institutional Trading of Axon Enterprise
Large investors have recently added to or reduced their stakes in the company. Hollencrest Capital Management acquired a new stake in Axon Enterprise in the first quarter valued at $29,000. Spire Wealth Management acquired a new stake in Axon Enterprise in the first quarter valued at $31,000. ICA Group Wealth Management LLC acquired a new stake in Axon Enterprise in the fourth quarter valued at $25,000. WealthPLAN Partners LLC acquired a new stake in Axon Enterprise in the first quarter valued at $35,000. Finally, U.S. Capital Wealth Advisors LLC acquired a new stake in Axon Enterprise in the fourth quarter valued at $29,000. Institutional investors and hedge funds own 75.62% of the company’s stock.
Axon Enterprise Company Profile
Axon Enterprise, Inc engages in the development, manufacture, and sale of conducted electrical weapons for personal defense. It operates through the TASER segment and Software and Sensors segment. The TASER segment sells conducted electrical weapons, accessories, and other related products and services.
- Get a free copy of the StockNews.com research report on Axon Enterprise (AXON)
- Airline ETFs: What They Are and How to Invest
- Williams-Sonoma Is The Retail Value Play, Here’s Why
- Ladder Corporation: Climbing Higher And Paying 9% Yield
- Microbot Medical spikes 150% on its Endovascular Surgical Robot
- PetMed Express: Charts Say This Could Be The Bottom
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.